A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for
Category: HIV treatment
Juluca for treating virologically suppressed HIV-1 Infection
FDA Approves Juluca (dolutegravir and rilpivirine) for the maintenance and treatment of virologically suppressed HIV-1 Infection. This is the first
HIV treatment prevents cognitive decline
HIV-positive patients have the same risk of dementia as any other person if they take viral-suppressing medication and live a
